Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
US Army
Express Scripts
McKesson
US Department of Justice
QuintilesIMS
Moodys
Cantor Fitzgerald

Generated: April 22, 2018

DrugPatentWatch Database Preview

PENTACEF Drug Profile

« Back to Dashboard

When do Pentacef patents expire, and when can generic versions of Pentacef launch?

Pentacef is a drug marketed by Glaxosmithkline and is included in three NDAs.

The generic ingredient in PENTACEF is ceftazidime. There are seventeen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the ceftazidime profile page.
Drug patent expirations by year for PENTACEF
Medical Subject Heading (MeSH) Categories for PENTACEF
Synonyms for PENTACEF
(6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(1-carboxy-1-methylethoxy)imino]acetyl}amino)-8-oxo-3-(pyridinium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(1-hydroxy-2-methyl-1-oxopropan-2-yl)oxyiminoacetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-(1-carboxy-1-methyl-ethoxy)imino-acetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-8-oxo-3-(pyridinium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1-[[(6R,7R)-7-[[(2Z)-(2-AMINO-4-THIAZOLYL)[(1-CARBOXY-1-METHYLETHOXY)IMINO] ACETYL] AMINO]-2-CARBOXY-8-OXO-5-THIA-1-AZABICYCLO[4.2.0] OCT-2-EN-3-YL]METHYL]PYRIDINUM HYDROXIDE INNER SALT
1-{[(6R,7R)-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(1-carboxy-1-methylethoxy)imino]acetamido]-2-carboxylato-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl}pyridin-1-ium
72558-82-8
78439-06-2
7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-3-(pyridinium-1-ylmethyl)-3,4-didehydrocepham-4-carboxylate
AB00513848
AB00513848-02
AB02837
AB1009357
AC1NUK7U
AK163513
AKOS015951273
AN-37419
BDBM50420259
BIDD:GT0734
C06889
C22H22N6O7S2
CAZ
Cefprozil, Antibiotic for Culture Media Use Only
Ceftazidim
ceftazidima
Ceftazidima [INN-Spanish]
ceftazidime
CEFTAZIDIME (ARGININE FORMULATION)
Ceftazidime (INN)
Ceftazidime (TN)
CEFTAZIDIME ACID
Ceftazidime anhydrous
Ceftazidime Sodium In Plastic Container
ceftazidimum
Ceftazidimum [INN-Latin]
Ceftazidine
Ceptaz
Ceptaz (TN)
CHEBI:3508
CHEMBL44354
CS-2810
D07654
DB00438
DTXSID5022770
Fortaz
Fortaz In Plastic Container
Fortum
GR 20263
HMS2090M13
HY-B0593
MolPort-006-137-763
Q-200811
SCHEMBL36849
SN 401
Tazicef
Tazidime
Tazidime In Plastic Container

US Patents and Regulatory Information for PENTACEF

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline PENTACEF ceftazidime INJECTABLE;INJECTION 063322-001 Nov 7, 1995 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Glaxosmithkline PENTACEF ceftazidime INJECTABLE;INJECTION 064006-002 Mar 31, 1992 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Glaxosmithkline PENTACEF ceftazidime INJECTABLE;INJECTION 064006-001 Mar 31, 1992 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Glaxosmithkline PENTACEF ceftazidime INJECTABLE;INJECTION 063322-002 Nov 7, 1995 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Accenture
Deloitte
Farmers Insurance
McKinsey
Moodys
US Department of Justice
Express Scripts
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.